Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy's makes senior changes as US generics head exits

UmangVohra will be replaced by Alok Sonig

Dr Reddy's Umang VohraDr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured).

Vohra is leaving the Indian generics-focused company after nearly three years as its executive VP and head North America Generics.

In total he spent 13 years with the firm, which he joined in 2002 from Pepsico-India, where he was financial planning manager.

Vohra's replacement at Dr Reddy's is the company's head of India generics Alok Sonig who, prior to joining the firm, served at Bristol-Myers Squibb, where he spent three years as managing director of BMS India.

To fill Sonig's vacant role Dr Reddy's has handed MV Ramana, currently executive vice president - emerging markets, additional responsibilities with a move to executive vice president and head branded markets (India and emerging countries).

1st September 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics